Cadence Capital Management’s Orthofix Medical OFIX Stock Holding History

Cadence Capital Management’s Portfolio OFIX Stock Details OFIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-56,218	Closed	-$2.97M	–	453
2019 Q2	$2.97M	Sell	56,218 -1,882	-3%	-$100K	0.3%	81
2019 Q1	$3.28M	Buy	58,100 +13,658	+31%	+$767K	0.29%	83
2018 Q4	$2.33M	Sell	44,442 -12,223	-22%	-$695K	0.24%	119
2018 Q3	$3.28M	Buy	56,665 +9,562	+20%	+$536K	0.18%	135
2018 Q2	$2.68M	Buy	47,103 +4,766	+11%	+$271K	0.16%	153
2018 Q1	$2.49M	Buy	42,337 +8,109	+24%	+$454K	0.16%	141
2017 Q4	$1.87M	Buy	34,228 +2,467	+8%	+$128K	0.12%	210
2017 Q3	$1.5M	Buy	+31,761	New	+$1.5M	0.09%	278

Other funds holding OFIX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Cadence Capital Management's OFIX Position: Q3 2019 in Review

Cadence Capital Management sold out of Orthofix Medical (OFIX) in Q3 2019, closing a stake of 56,218 shares — an estimated $2.97M sold.

Cadence Capital Management first reported a position in OFIX in Q3 2017 and held it in 8 quarters. The position peaked at $3.28M in Q1 2019. 158 funds tracked by Wall St. Rank hold OFIX as of Q3 2019.

Cadence Capital Management reported no remaining Orthofix Medical position as of Q3 2019 after selling out during the quarter.
Cadence Capital Management sold 56,218 Orthofix Medical shares in Q3 2019, an estimated $2.97M.
Cadence Capital Management first reported a position in Orthofix Medical in Q3 2017 and held it in 8 quarters.
Cadence Capital Management's Orthofix Medical position peaked at $3.28M in Q1 2019.
158 funds tracked by Wall St. Rank held Orthofix Medical as of Q3 2019.

Based on Cadence Capital Management's 13F filing for Q3 2019, filed 29 Oct 2019.